These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 32261106)

  • 1. Poly-l-lysine assisted synthesis of core-shell nanoparticles and conjugation with triphenylphosphonium to target mitochondria.
    Wang XH; Peng HS; Yang L; You FT; Teng F; Tang AW; Zhang FJ; Li XH
    J Mater Chem B; 2013 Oct; 1(38):5143-5152. PubMed ID: 32261106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of Fluorescent Dye-Doped Biocompatible Nanoparticles for Cell Labeling.
    Wang X; Peng H; Huang S; You F
    J Nanosci Nanotechnol; 2016 Apr; 16(4):3602-7. PubMed ID: 27451673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymer-polymer conjugation to fabricate multi-block polymer as novel drug carriers: poly(lactic acid)-poly(ethylene glycol)-poly(L-lysine) to enhance paclitaxel target delivery.
    Liu Y; Liu C; Li M; Liu F; Feng L; Zhang L; Zhang N
    J Biomed Nanotechnol; 2014 Jun; 10(6):948-58. PubMed ID: 24749390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
    Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioreducible Poly(ethylene glycol)-Triphenylphosphonium Conjugate as a Bioactivable Mitochondria-Targeting Nanocarrier.
    Khatun Z; Choi YS; Kim YG; Yoon K; Nurunnabi M; Li L; Lee E; Kang HC; Huh KM
    Biomacromolecules; 2017 Apr; 18(4):1074-1085. PubMed ID: 28257184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
    Liu P; Yu H; Sun Y; Zhu M; Duan Y
    Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cRGD conjugated mPEG-PLGA-PLL nanoparticles for SGC-7901 gastric cancer cells-targeted Delivery of fluorouracil.
    Liu P; Wang H; Wang Q; Sun Y; Shen M; Zhu M; Wan Z; Duan Y
    J Nanosci Nanotechnol; 2012 Jun; 12(6):4467-71. PubMed ID: 22905486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling.
    Babic M; Horák D; Trchová M; Jendelová P; Glogarová K; Lesný P; Herynek V; Hájek M; Syková E
    Bioconjug Chem; 2008 Mar; 19(3):740-50. PubMed ID: 18288791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RGD-conjugated PLA-PLL nanoparticles targeting to Bacp-37 breast cancer xenografts in vivo.
    Liu P; Qi X; Sun Y; Wang H; Li Y; Duan Y
    J Nanosci Nanotechnol; 2011 Dec; 11(12):10760-4. PubMed ID: 22408990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly-L-lysine-coated albumin nanoparticles: stability, mechanism for increasing in vitro enzymatic resilience, and siRNA release characteristics.
    Singh HD; Wang G; Uludağ H; Unsworth LD
    Acta Biomater; 2010 Nov; 6(11):4277-84. PubMed ID: 20601248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photosensitizer-mediated mitochondria-targeting nanosized drug carriers: Subcellular targeting, therapeutic, and imaging potentials.
    Choi YS; Kwon K; Yoon K; Huh KM; Kang HC
    Int J Pharm; 2017 Mar; 520(1-2):195-206. PubMed ID: 28179191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Charge-driven flocculation of poly(L-lysine)-gold nanoparticle assemblies leading to hollow microspheres.
    Murthy VS; Cha JN; Stucky GD; Wong MS
    J Am Chem Soc; 2004 Apr; 126(16):5292-9. PubMed ID: 15099114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria-targeted alginate/triphenylphosphonium-grafted-chitosan for treatment of hepatocellular carcinoma.
    Arafa KK; Hamzawy MA; Mousa SA; El-Sherbiny IM
    RSC Adv; 2022 Aug; 12(34):21690-21703. PubMed ID: 35975035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjugation of Triphenylphosphonium Cation to Hydrophobic Moieties to Prepare Mitochondria-Targeting Nanocarriers.
    Guzman-Villanueva D; Mendiola MR; Nguyen HX; Yambao F; Yu N; Weissig V
    Methods Mol Biol; 2019; 2000():183-189. PubMed ID: 31148015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
    Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the synthesis of mucus permeating nanocarriers.
    Bourganis V; Karamanidou T; Samaridou E; Karidi K; Kammona O; Kiparissides C
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):239-49. PubMed ID: 25661586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and optimization of ZnPc-loaded biocompatible nanoparticles for efficient photodynamic therapy.
    Ping JT; Peng HS; Duan WB; You FT; Song M; Wang YQ
    J Mater Chem B; 2016 Jul; 4(25):4482-4489. PubMed ID: 32263431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of Paclitaxel in biodegradable self-assembled core-shell poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles.
    He X; Ma J; Mercado AE; Xu W; Jabbari E
    Pharm Res; 2008 Jul; 25(7):1552-62. PubMed ID: 18196205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-Assembly of Fluorescent Hybrid Core-Shell Nanoparticles and Their Application.
    Wang C; Tang F; Wang X; Li L
    ACS Appl Mater Interfaces; 2015 Jun; 7(24):13653-8. PubMed ID: 26031912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.